People · Operator
Named in public records as an officer, director or promoter · active 2010–2019 · Biotechnology, Healthtech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cidara Therapeutics, Inc. | — | Biotechnology | Series D+ | $349.1M | $2.8B | 2014 |
| Ajax Health II LLC | — | Healthtech | Series C | $51.0M | $1.3B | 2019 |
| Cenerx Biopharma Inc | — | Biotechnology | Series A | $33.3M | $186.3M | 2010 |
| NEXTWAVE PHARMACEUTICALS Inc | — | Pharmaceuticals | Series B | $27.2M | $925.9M | 2011 |
Steve Elms at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steve Elms on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Garheng Kong | 1 | 16 |
| Nina Kjellson | 1 | 11 |
| Patrick Heron | 1 | 11 |
| SCOTT ROCKLAGE | 1 | 9 |
| Anthony Sun | 1 | 8 |
| ANAND MEHRA | 1 | 7 |
| TING PAU OEI | 1 | 7 |
| Douglas Koo | 1 | 7 |
| Steven Elms | 1 | 5 |
| Douglas Rohlen | 1 | 5 |
| Jeffrey Stein | 1 | 4 |
| Theodore R. Schroeder | 1 | 4 |
| Scott M. Rocklage | 1 | 4 |
| Dayton Misfeldt | 1 | 4 |
| Dirk Thye | 1 | 3 |
| Linda Ara | 1 | 3 |
| Kevin Judice | 1 | 3 |
| Gaurav Aggarwal | 1 | 3 |
| Arthur Pappas | 1 | 3 |
| Kevin Forrest | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.